Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene (LRRK2) Influence Parkinson's Disease Susceptibility?

Omics : a journal of integrative biology - 1 Apr 2016

Yılmaz Şenay Görücü, Geyik Sırma, Neyal Ayşe Münife, Soko Nyarai D, Bozkurt Hakan, Dandara Collet

Abstract excerpt

Parkinson's disease (PD) is a frequently occurring neurodegenerative motor disorder adversely impacting global health. There is a paucity of biomarkers and diagnostics that can forecast susceptibility to PD. A new research frontier for PD pathophysiology is the study of variations in microRNA (miRNA) expression whereby miRNAs serve as "upstream regulators" of gene expression in relation to functioning of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MicroRNAs

Share to Parkinson Disease

Source

Identifiers

PMID: 27093107
DOI: 10.1089/omi.2016.0040

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene (LRRK2) Influence Parkinson's Disease Susceptibility?PMID 27093107Read ↗

Circulating Inflammatory miRNAs Associated with Parkinson’s Disease PathophysiologySemantic proximity Read ↗

LRRK2 and Parkinson disease.Semantic proximity Read ↗

Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson's Disease.Semantic proximity Read ↗

Leucine-Rich Repeat Kinase 2 in Parkinson’s Disease: Updated from Pathogenesis to Potential Therapeutic TargetSemantic proximity Read ↗

Gene and MicroRNA transcriptome analysis of Parkinson's related LRRK2 mouse models.Semantic proximity Read ↗

Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson’s DiseaseSemantic proximity Read ↗

Low Levels of LRRK2 Gene Expression are Associated with LRRK2 SNPs and Contribute to Parkinson's Disease Progression.Semantic proximity Read ↗

Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study.Semantic proximity Read ↗

MicroRNAs in Parkinson’s disease: A systematic review and diagnostic accuracy meta-analysisSemantic proximity Read ↗

The screening of the 3'UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's disease.Semantic proximity Read ↗

LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting.Semantic proximity Read ↗

Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.